You can view the research column published every month by SMC Laboratories.
2025.02.03
We are delighted to announce the launch of our new in vitro assay service for fibrosis evaluation. &nbs…
2025.02.03
Today, we would like to introduce an example of a proof-of-concept study of adiponectin-derived peptide ALY688…
2025.02.03
We would like to introduce a non-invasive biomarkers for Idiopathic Pulmonary Fibrosis (IPF) disease models. &…
2025.02.03
Today, we would like to introduce a paper published by our client using our non-alcoholic steatohepatitis (NAS…
2025.02.03
We would like to introduce the dextran sulfate sodium (DSS) -induced colitis model, which is a clinically repr…
2025.02.03
Advantages of using multiple MASH models; STAMTM x GAN diet – Comprehensively covers criteria for…
2025.02.03
We would like to inform you that we have extended our drug efficacy evaluation study services for male bleomyc…
2025.02.03
We would like to share some examples of how our NASH-HCC model (STAMTM model) can be used for fundamental rese…
2025.02.03
We would like to introduce the acquisition of RNA sequencing data from STAMTM mice which we hope to utilize to…
2025.02.03
We would like to introduce the data we obtained from a recently conducted bleomycin-induced lung fibrosis stud…
We can help you advance your research.